Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-16

Clinical Trial Update: The BEACON Trial: Diagnostic Tools for Breast Lymphedema After Treatment for Breast Cancer

View source ↗

Summary

The BEACON trial is evaluating diagnostic tools for breast lymphedema following breast cancer treatment and is currently enrolling by invitation at Massachusett…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Breast Edema, Breast Lymphedema | Status: ENROLLING_BY_INVITATION